{
  "meta": {
    "title": "Plasma_Cell_Disorders",
    "url": "https://brainandscalpel.vercel.app/plasma-cell-disorders-878d4bd5.html",
    "scrapedAt": "2025-12-01T04:07:52.807Z"
  },
  "questions": [
    {
      "text": "<p>A 64-year-old man comes to the office due to 3 months of constant, dull, low back pain that is worse with movement.&nbsp; The patient has also had intermittent episodes of difficult&nbsp;urination&nbsp;over the last year.&nbsp; He has no other medical conditions and takes no medications.&nbsp; The patient smoked a pack of cigarettes daily for 15 years but quit 10 years ago.&nbsp; Vital signs are within normal limits.&nbsp; On physical examination, the lungs are clear and heart sounds are normal.&nbsp; The abdomen is soft and nontender with no hepatosplenomegaly.&nbsp; Digital rectal examination shows a diffusely enlarged prostate with no nodules.&nbsp; Laboratory testing reveals a serum creatinine level of 1.9 mg/dL.&nbsp; Urine dipstick testing is within normal limits, but 24-hour urinary protein excretion is elevated.&nbsp; Urine microscopy shows waxy, laminated casts.&nbsp; Imaging of the spine demonstrates diffuse osteopenia and multiple irregular, radiolucent lesions in the thoracic and lumbar vertebrae.&nbsp; Which of the following histopathologic findings is most likely associated with the development of this patient&#39;s bone lesions?</p>",
      "choices": [
        {
          "id": 1,
          "text": "Branching papillae lined by cuboidal cells with overlapping nuclei"
        },
        {
          "id": 2,
          "text": "Infiltrating glandular cells with substantial adjacent osteoblasts"
        },
        {
          "id": 3,
          "text": "Large, malignant cells containing keratin and intercellular bridges"
        },
        {
          "id": 4,
          "text": "Clusters of mature plasma cells and plasmablasts"
        },
        {
          "id": 5,
          "text": "Sheets of round or polygonal cells with abundant clear cytoplasm"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Pathology > Hematology & Oncology > Multiple myeloma</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><div id=\"div_t42281\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Multiple myeloma</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>Plasma cell neoplasm produces <strong>monoclonal </strong>paraprotein (immunoglobulin)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Manifestations</strong></p></td><td><ul><li>Bone pain, fractures</li><li>Constitutional symptoms (weight loss, fatigue)</li><li>Recurrent infections</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory </strong></p></td><td><ul><li>Normocytic anemia</li><li>Renal insufficiency</li><li>Hypercalcemia (constipation, muscle weakness)</li><li>Monoclonal paraproteinemia <strong>(M-spike)</strong></li></ul></td></tr><tr><td><p align=\"center\"><strong>Radiology</strong></p></td><td><ul><li><strong>Osteolytic lesions</strong>/osteopenia (osteoclast activation)</li></ul></td></tr></tbody></table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div><p>This older patient with back pain has several irregularly-shaped vertebral lesions, raising strong suspicion for metastatic disease.&nbsp; Differentiation of the <a href=\"8301\">underlying tumor</a> is often assisted by whether the lesion is sclerotic (osteoblastic) or radiolucent (osteolytic).&nbsp; <strong>Multiple myeloma</strong>, a clonal plasma cell malignancy, is one of the most common causes of <strong>radiolucent bone lesions</strong> in adults; the tumor multiplies in the bone marrow and generates osteolytic cytokines, causing bone pain, bone destruction, pathologic fractures, and hypercalcemia.</p><p>Myeloma cells also produce excessive <strong>monoclonal immunoglobulin</strong> (paraprotein) that can clog the renal tubules and subsequently cause <strong>light-chain cast nephropathy</strong>.&nbsp; This is typically characterized by mild <strong>renal insufficiency</strong>, normal urine dipstick for protein (detects albumin only), elevated 24-hour urine protein (can detect&nbsp;light-chain proteins), and waxy, laminated casts.&nbsp; Excessive light chains can also form fibrils and deposit in tissues, leading to amyloid light-chain amyloidosis.&nbsp; Monoclonal immunoglobulins are identified by urine or serum protein electrophoresis (M-spike).</p><p>The diagnosis of myeloma is confirmed by bone marrow aspirate or biopsy, which will demonstrate &#8805;10% clonal <strong>plasma cells</strong>.&nbsp; <a href=\"19373\">Plasma cells</a> are identified based upon &#x22;clock-face&#x22; chromatin, abundant basophilic cytoplasm, and prominent perinuclear clear areas (Golgi apparatus).</p><p><strong>(Choice A)</strong>&nbsp; <a href=\"46009\">Papillary thyroid cancer</a> is characterized by branching papillae lined by cuboidal cells with overlying nuclei (often with calcified psammoma bodies).&nbsp; Most cases progress slowly and present with a thyroid mass that may invade adjacent structures; bone lesions are relatively uncommon.</p><p><strong>(Choice B)</strong>&nbsp; <a href=\"46100\">Prostate adenocarcinoma</a> is a glandular tumor that often spreads to the bones.&nbsp; However, it produces sclerotic (osteoblastic) bone lesions, not radiolucent bone lesions.&nbsp; Furthermore, prostate cancer does not generally impinge on the urethra (urinary symptoms uncommon) and is usually associated with a nodule on prostate examination; this patient&#39;s intermittent difficulty urinating and diffusely enlarged prostate with no nodules likely indicate benign prostatic hyperplasia.</p><p><strong>(Choices C and E)</strong>&nbsp; <a href=\"41746\">Squamous cell lung cancer</a> is associated with large, malignant cells containing keratin with intercellular bridges.&nbsp; <a href=\"46101\">Renal cell carcinoma</a> is associated with sheets of round or polygonal cells with abundant clear cytoplasm.&nbsp; Although both tumors commonly form osteolytic lesions in the spine, neither regularly cause renal insufficiency, elevated urine protein, and waxy urinary casts.</p><p><strong>Educational objective:</strong><br>Multiple myeloma is a plasma cell malignancy that replicates in the bone marrow and causes osteolytic bone lesions, bone destruction, hypercalcemia, and pathologic fractures.&nbsp; Histopathology will show replacement of the normal bone marrow with plasma cells and plasmablasts.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "14064",
      "difficulty": "N/A"
    },
    {
      "text": "<p>A 64-year-old man comes to the office due to several weeks of worsening back pain, fatigue, and polyuria.&nbsp; Physical examination reveals mucosal pallor and diffuse bony tenderness.&nbsp; Laboratory studies are significant for normocytic anemia, hypercalcemia, and renal failure.&nbsp; Serum protein electrophoresis demonstrates a monoclonal spike in the gamma globulin region.&nbsp; Bone marrow biopsy shows a large number of abnormal plasma cells.&nbsp; Treatment with lenalidomide is started; this medication increases affinity of E3 ubiquitin ligase enzyme to substrate transcription factors.&nbsp; Which of the following is the most likely effect of this medication on these transcription factors?</p>",
      "choices": [
        {
          "id": 1,
          "text": "Decreased cell surface expression"
        },
        {
          "id": 2,
          "text": "Decreased lysosomal proteolysis"
        },
        {
          "id": 3,
          "text": "Increased binding to promoter region"
        },
        {
          "id": 4,
          "text": "Increased intracellular degradation"
        },
        {
          "id": 5,
          "text": "Increased nuclear translocation"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Pharmacology > Hematology & Oncology > Multiple myeloma</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><p><strong>Multiple myeloma</strong> is a plasma cell neoplasm associated with the overproduction of <strong>monoclonal immunoglobulins</strong>.&nbsp; Proliferation of neoplastic plasma cells in the bone marrow often causes bone pain (eg, back pain), hypercalcemia (eg, polyuria), and osteolytic lesions; patients also frequently develop normocytic anemia and renal insufficiency.&nbsp; Treatment frequently includes medications that inhibit proteasome activity (eg, bortezomib) or increase ubiquitination of regulatory proteins produced in excess in neoplastic cells (eg, <strong>lenalidomide</strong>).</p><p>Lenalidomide is a derivative of thalidomide, an antiemetic agent used in pregnancy until significant teratogenic effects were identified.&nbsp; Lenalidomide increases the binding affinity of the <strong>E3 ubiquitin ligase complex</strong> to specific <strong>transcription factors</strong> (TFs) (eg, Ikaros and Aiolos 2 zinc finger transcription factors) that are overexpressed in myeloma cells.&nbsp; Binding attaches ubiquitin to the TFs, which leads to their subsequent <strong>destruction by the proteasome</strong>.&nbsp; Because these TFs are required for myeloma cell survival, diminished intracellular concentrations cause cell death.&nbsp; Other mature B-cell malignancies such as mantle cell lymphoma and myelodysplastic syndrome (some cases are caused by B-cell proliferation) also overexpress these TFs; therefore, lenalidomide is often effective against these neoplasms.</p><p><strong>(Choice A)</strong>&nbsp; TFs are proteins that bind to a specific DNA sequence to increase or suppress its transcription to messenger RNA; they are not expressed on the cell surface.</p><p><strong>(Choice B)</strong>&nbsp; Lysosomes are membrane-bound organelles with hydrolytic enzymes that break down molecules from outside the cell (via endocytosis) or within the cytoplasm (autophagy).&nbsp; Although lysosomes and proteasomes are the 2 major pathways of protein degradation in the cell, lysosomes digest proteins independent of ubiquitination; therefore, lenalidomide does not alter lysosome proteolysis.</p><p><strong>(Choice C)</strong>&nbsp; Ubiquitin binding does not alter the way TFs interact with DNA; instead, it results in increased proteolysis of the TFs by proteasomes.&nbsp; In contrast, phosphorylation or acetylation can affect TF binding to promoter regions of DNA.</p><p><strong>(Choice E)</strong>&nbsp; Proteins targeted for the nucleus have nuclear localization signals, short chains of amino acids that promote transport into the nucleus.&nbsp; These are added during protein synthesis in the endoplasmic reticulum; ubiquitination does not affect nuclear localization.</p><p><strong>Educational objective:</strong><br>Multiple myeloma is often treated with medications that block proteasome activity (eg, bortezomib) or increase ubiquitination of specific transcription factors (eg, lenalidomide).&nbsp; Lenalidomide increases E3 ubiquitin ligase binding to transcription factors overexpressed in myeloma, which results in increased transcription factor destruction by the proteosome and subsequent cancer cell death.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "19147",
      "difficulty": "N/A"
    }
  ]
}